Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

AZYTHROMYCIN

Popular

Description

License-out offer for azythromycin API technology         

                                             Member of Farmavita.net offers know-how for fermentation process for manufacture of active pharmaceutical ingredient of tazythromycin. Know how is available as non-exclusive license with lump sum payment.

Payment is made after yield and quality of API is confirmed in the laboratory. Guarantied process parameters

AZYTHROMYCIN

Antibacterial

Final yield : 31.2% from

Erythromycin A

Chemical synthesis

Offer is valid subject to confirmation, country by country. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent we do our the best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties. 

 

 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 467

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I want to give process knowhow and NON GMO...
n/a
111 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
240 Views
 Company portfolio: Manufacturing over 100...
459 Views
Objective: To enter into EU domain procuring...
484 Views
Objective: To enter into EU domain grabbing a...
226 Views
OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF...
264 Views
Please contact me.  if you need...
752 Views